文献速递心境障碍

活动依赖性BDNF释放是东莨菪碱快速抗抑郁作用的必要条件

Activity-Dependent Brain-Derived Neurotrophic Factor Release Is Required for the Rapid Antidepressant Actions of Scopolamine.
PubMed 文献 · Biol Psychiatry · 2017-06-23

该研究在BDNF Val/Met敲入小鼠中评估东莨菪碱的行为效应,并通过内侧前额叶皮层注射BDNF中和抗体测试BDNF释放的必要性。结果表明BDNF Met/Met小鼠对东莨菪碱反应减弱,抗BDNF抗体阻止其抗抑郁样行为效应,且该效应依赖AMPA受体激活和电压依赖性钙通道。

要点

  • BDNF Met/Met小鼠对东莨菪碱的抗抑郁样行为反应减弱。
  • 内侧前额叶皮层注射BDNF中和抗体可阻止东莨菪碱的行为效应。
  • 东莨菪碱快速刺激BDNF释放及TrkB-ERK信号,依赖AMPA受体和电压依赖性钙通道。

核心结论

  • 活动依赖性BDNF释放是东莨菪碱快速抗抑郁效应所必需的。
  • BDNF Met等位基因携带者可能对东莨菪碱反应较弱。

研究设计与样本

  • 在BDNF Val/Met敲入小鼠中评估东莨菪碱的行为效应。
  • 通过内侧前额叶皮层注射BDNF中和抗体测试BDNF释放的必要性。
  • 进行体内和体外实验探讨BDNF依赖机制。

主要发现

  • BDNF Met/Met小鼠对东莨菪碱的反应减弱。
  • 内侧前额叶皮层注射抗BDNF抗体阻止东莨菪碱的抗抑郁样行为效应。
  • 东莨菪碱快速刺激BDNF释放和TrkB-ERK信号。
  • 上述效应需要AMPA受体激活,并被神经元沉默阻断。
  • 维拉帕米预处理阻止东莨菪碱诱导的行为反应和BDNF-TrkB信号。

临床怎么用

  • BDNF Met等位基因可能作为东莨菪碱疗效的潜在生物标志物。
  • 调节BDNF释放或TrkB信号可能增强东莨菪碱的抗抑郁作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Brain-derived neurotrophic factor (BDNF) plays a key role in the pathophysiology and treatment of depression. Recent clinical studies demonstrate that scopolamine, a nonselective muscarinic acetylcholine receptor antagonist, produces rapid antidepressant effects in patients with depression. Rodent studies demonstrate that scopolamine increases glutamate transmission and synaptogenesis in the medial prefrontal cortex (mPFC). Here we tested the hypothesis that activity-dependent BDNF release within the mPFC is necessary for the antidepressant actions of scopolamine. METHODS: Behavioral effects of scopolamine were assessed in BDNF Val/Met knock-in mice, in which BDNF processing and release are impaired. In addition, intra-mPFC infusion of a BDNF-neutralizing antibody was performed to test the necessity of BDNF release in driving scopolamine-induced behavioral responses. Further in vivo and in vitro experiments were performed to delineate BDNF-dependent mechanisms underlying the effects of scopolamine. RESULTS: We found that BDNF Met/Met mice have attenuated responses to scopolamine and that anti-BDNF antibody infusions into the mPFC prevented the antidepressant-like behavioral effects of scopolamine. In vitro experiments show that scopolamine rapidly stimulates BDNF release and tropomyosin receptor kinase B-extracellular signal-regulated kinase signaling. Moreover, these effects require alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor activation and are blocked by neuronal silencing. Importantly, pretreatment with verapamil prevented scopolamine-induced behavioral responses and BDNF-tropomyosin receptor kinase B signaling, suggesting that these effects are dependent on activation of voltage-dependent calcium channels. CONCLUSIONS: The results identify an essential role for activity-dependent BDNF release in the rapid antidepressant effects of scopolamine. Attenuation of responses in BDNF Met mice indicates that patients with the Met allele may be less responsive to scopolamine.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Ghosal S, Bang E, Yue W, et al. Activity-Dependent Brain-Derived Neurotrophic Factor Release Is Required for the Rapid Antidepressant Actions of Scopolamine. Biol Psychiatry. 2017. PMID: 28751069. doi:10.1016/j.biopsych.2017.06.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。